Health minister dismisses key recommendation from expert report on pharmacare
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Monthly Digital Subscription
$0 for the first 4 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*No charge for 4 weeks then price increases to the regular rate of $19.00 plus GST every four weeks. Offer available to new and qualified returning subscribers only. Cancel any time.
Monthly Digital Subscription
$4.75/week*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $19 plus GST every four weeks. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
*Your next subscription payment will increase by $1.00 and you will be charged $16.99 plus GST for four weeks. After four weeks, your payment will increase to $23.99 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
OTTAWA – Health Minister Marjorie Michel is dismissing the key finding of an expert advisory committee on pharmacare, which says Ottawa should fully fund a list of essential medicines without cutting deals with the premiers.
The committee’s report, released Friday, says the federal government should create the list and provide funding to ensure all Canadians can get essential medication at no cost.
The chair of the committee says it’s clear trying to negotiate bilateral deals with the provinces and territories doesn’t work.
Michel shook her head when asked about that recommendation today, saying the provinces and territories are responsible for delivering health care and her government’s role is to negotiate with them.
She also pointed out that the committee’s report is not binding on the government.
The expert committee was a requirement of the Pharmacare Act that the Trudeau Liberal government passed into law just over a year ago.
This report by The Canadian Press was first published Nov. 24, 2025.